Anecdotal reports from users have included: Commonly Reported: Injection site pain, redness, or swelling Mild dizziness Nausea Fatigue or drowsiness Less Commonly Reported: Anxiety or mood changes Heart palpitations Insomnia Loss of appetite Depression or anhedonia The FDA has noted that BPC-157 may pose an immunogenicity risk (triggering an immune response)
The peptide is unaffected dilution changes the volume per dose, not the compound
Full-spectrum supplies the mushroom's active nootropics, which are called hericenones and erinacines
PMOS is heterogeneous the same diagnosis in different women can have very different dominant drivers
Despite its multiple beneficial roles, concerns about glutathiones effects on hair, such as hair greying or whitening, have emerged in recent discussions
For comprehensive background, the peptides for autoimmune diseases guide covers the current state of research